This notion is supported by our recent unpublished results that VEGFR2 levels in METCAM/MUC18-expressing human breast cancer SK-BR-3 tumors were at least two-fold higher than in the vector control SK-BR-3 tumors [26,27]. The gene discussed is MCAM; the disease is breast cancer.